Associate Group Medical Director Pharma Development - Immunology, Genentech
Internal Medicine
Dr. James A. Thommes, MD
James A. Thommes, MD works in the field of Internal Medicine. Doctor James A. Thommes, MD is a published doctor as well. He has 16 publications published. The latest was: Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III cli...
Publications
- Ritonavir-boosted danoprevir-based regimens in treatment-naive and prior null responders with HCV genotype 1 or 4 and compensated cirrhosis.
- The Effect of Mild to Moderate Renal Impairment on the Pharmacokinetics of the Nucleoside Analog Hepatitis C Virus Polymerase Inhibitor Mericitabine.
- JUMP-C: A randomized trial of mericitabine plus peginterferon alfa-2a/ribavirin for 24 weeks in treatment-naive HCV genotype 1/4 patients.
- Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial.
- Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy.
- Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III cli...
- Induction pegylated interferon alfa-2a and high dose ribavirin do not increase SVR in heavy patients with HCV genotype 1 and high viral loads.
- Association between specific enfuvirtide resistance mutations and CD4 cell response during enfuvirtide-based therapy.
- Quality of life and tolerability after administration of enfuvirtide with a thin-walled needle: QUALITE Study.
- Short communication safety, tolerability and pharmacokinetics of enfuvirtide administered by a needle-free injection system compared with subcutaneous injection.
- Adherence to enfuvirtide and its impact on treatment efficacy.
- Limited positive predictive value of resistance testing in treatment-experienced patients.
- 9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial.
- Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients.
- Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing.
Schools
Southern Illinois University At Edwardsville
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
University of California, Irvine -
UCLA San Fernando Valley Program -
Grand Rapids Medical Education Partners - MSUCOM
Helpful Reviews
Similar Doctors
|
Dr. Amir H. Nejad, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ajit Mannan, MD |
|
|
Dr. Elena T. Chetver, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Parham Zarrini, MD |
|
|
Dr. Joshua F. Lewis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul Hwu, MD
This Doctor is OpenDoctor Recommended.
|